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e new binuclear niobium(V) complexes of the type [[NbO(L)C4H4O6]2C4H4O6] (where L =DMH, IMH, IPH, FPH, TMT)
were prepared with biologically important drugs and characterized by using elemental analysis; IR, 1H-NMR, and UV-Vis spectral
studies, and thermogravimetric analysis. e molar conductance measurement of all the complexes in DMF solution corresponds
to 1 : 1 electrolytic nature. All complexes were of the pure diamagnetic character and were found to have six-coordinate octahedral
geometry. e antimicrobial activity of these complexes has been screened against two Gram-positive and two Gram-negative
bacteria. Antifungal activity against two different fungi has been evaluated and compared with controls. All the complexes inhibit
the growth of both Gram-positive and Gram-negative bacteria to a competent level.
1. Introduction
Metal ions play a vital role in a vast number of biological
processes. Niobium ions form complex species with virtually
all types of neutral and anionic donors. Niobium and its
compounds have a broad spectrum of applications. ey
are used for the fabrication of special materials for micro-
electronics and optics, superconductors, refractorymaterials,
catalysts, and alloys [1–5]. As an important alloy element in
steels, niobium can greatly affect the properties of a sample,
such as the intensity at high temperature, the ability of
tarnish resistance, and temper brittleness [6, 7]. Niobium
steels are valuable constructive materials for the chemical
and nuclear industries, jet and rocket engines, gas pipelines,
and turbines [8]. e chemistry of the early transition metal
peroxo complexes has received special attention due to their
importance in a variety of biological, pharmaceutical, and
industrial processes [9]. Uses of metal ions in therapeutic
agents are known to accelerate drug action, and their efficacy
is enhanced upon the coordination with a metal ion [10].
e antimicrobial properties of metal complexes have been
recognized for centuries and have represented some of the
most fundamental breakthroughs in medicinal history [11].
However, Nb(V) complexes have been limitedly studied as
the biocidal agents [12, 13]. us, we intended to study the
ability of niobium complexes as good antimicrobial agents.
e present work describes the preparation of new nio-
bium(V) tartrate complexes containing active pharmaceuti-
cal drugs (Figure 1). e isolated complexes were studied
via elemental analysis; IR, 1H-NMR, and UV spectroscopies;
and TGA. In view of the biological activity of the complexes
and diverse coordinating ability of the ligands, we were
provoked to study the niobium(V) complexes of nitrogen-
based ligands against microbial strains, namely, E. coli, S.
aureus, P. aeruginosa, and B. subtilis, and fungal strains A.
�avus and A. niger were undertaken to study their role as
microbial compounds.
2. Experimental
2.1. Materials. e ligands IPH (isothipendyl hydrochloride,
SKF Ltd., India), IMH (imipramine hydrochloride, Sun Phar-
maceuticals Ltd., India), DMH (desipramine hydrochloride,





















F 1: Structure of the pharmaceutical drugs.
Smith Kline and Beecham Ltd., India), FPH (�uphenazine
dihydrochloride, SKF Ltd., India), and TMT (trimeprazine
tartrate, Intas Laboratories Ltd., India), were received from
pharmaceutical industries as gi samples and used as
received. Among the solvents employed, DMF and DMSO
were of spectroscopic grade and remaining solvents were of
AR grade.
2.2. Preparation of Niobium(V) Solution. Niobium(V) solu-
tion was prepared [14] by fusion of 0.05 g of niobium pentox-
ide with 2 g of potassium pyrosulphate in a silica crucible and
leaching the mass with 20mL of 10% tartaric acid solution.
e solution was then diluted to 100mL using water, and
this solutionwas used for the preparation of complexes. Fresh
solutions were prepared whenever required.
2.3. Physical Measurements. FTIR spectra for samples were
recorded using Jasco FT-IR-4100 spectrometer. 1H-NMR
spectra were recorded in DMSO-d6 on AMX-400 FT-NMR
spectrometer. Electronic spectra of the complexes in the UV-
Visible region (200–900 nm) were measured using a Jasco
UVIDEC-610 double-beam spectrophotometer with quartz
cells. Electrical conductance measurements of the prepared
complexes were done using an Elico CM-180 conductometer.
Melting points were determined in an open capillary tube
on Mel-temp apparatus. Magnetic susceptibility data in the
room temperature were obtained from Gouy method using
Hg[Co(SCN)4] as a calibrant. e TG and DTA patterns of
the complexes were recorded on a Perkin Elmer US TGA-7
analyzer in the atmosphere of air. e carbon, hydrogen,
and nitrogen contents of the complexes were determined by
CHNS analyzer. Tartrate was determined volumetrically by
using chloramines-T. Niobiumwas estimated gravimetrically
by direct ignition to Nb2O5 [15].
2.4. Antibacterial Activity. e in vitro biocidal activities
of the ligands and their niobium(V) complexes were tested
against four bacteria namely, S. aureus, E. coli, P. aeraginosa
and B. subtilius by disk diffusion method [16].
e pure cultures of these organisms were obtained
from the Department of Biotechnology, Bapuji Institute
of Engineering and Technology, Davangere. e organisms
used in the compounds were subcultured into sterile nutrient
broth. Aer incubating the same organisms at 37∘C for 3 h,
the growth thus obtained was used as inoculums for the tests.
Nutrient agar (28 gL−1) and nutrient broth were sterilized
in conical �ask of suitable capacity by autoclaving at 15 lb
pressure for 30min. e agar medium was melted on water
bath and cooled to 45∘C. To the 20–25mL molten agar
0.5–0.7mL of 3-h-old sub culture was added aseptically,
mixed well by gentle shaking, and allowed to attain room
temperature in Petri dishes. e sterilized �lter paper disks
(Whatman 41) were loaded with known volume of the test
compound of known strength using micropipette to get the
disk of desired concentration. e disks are placed over the
growthmedia seeded withmicroorganisms, le for diffusion,
and incubated at 37 ± 2∘C for 24 h. e experiment is carried
out with four replicates for each concentration.e antibiotic
chloramphenicol was also screened under similar conditions
for comparison as a standard, and the solvent DMSOwas also
put to know the activity.
2.5. Antifungal Activity. Antifungal activity of the test com-
pounds was determined against two fungi, A. �avus and A.
niger, by Bateman poisoned food technique [17]. ese fungi
were cultured for seven days on Czapek’s agar in sterilized
petri dishes under 12/12 h light and darkness. e ligand
and its metal complexes dissolved in DMSO were added to
10–15mL of sterilized media to achieve different concentra-
tions at 35 ± 2∘C and allowed the media for solidi�cation.
e test fungi were taken as 2mmdisks from 10-day-old pure
colonies and placed in the petri plates containing Czapek’s
agar nutritive medium. e experiments were carried out
in four replicates per treatment, and incubation was carried
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T 1: Physical analytical and molar conductance data of niobium(V) complexes.
Complex Found (Calc.) % Λ Ohm−1 cm2 mol−1
C H N S
(𝟏𝟏𝟏 [NbO(DM)C4H4O6]2C4H4O6
47.32 4.64 4.52 — 81
(48.29) (4.69) (4.69)
(𝟐𝟐𝟏 [NbO(IM)C4H4O6]2C4H4O6
48.78 4.84 4.59 — 83
(49.14) (4.91) (4.58)
(𝟑𝟑𝟏 [NbO(IP)C4H4O6]2C4H4O6
42.22 4.04 6.72 5.03 78
(42.89) (4.06) (6.82) (5.19)
(𝟒𝟒𝟏 [NbO(FP)C4H4O6]2C4H4O6
43.48 4.52 7.55 4.33 77
(44.53) (4.56) (7.99) (4.56)
(𝟓𝟓𝟏 [NbO(TM)C4H4O6]2C4H4O6
45.18 4.42 4.33 5.05 84
(45.82) (4.45) (4.45) (5.09)
out at 22 ± 2∘C under 12/12 light and darkness. e radical
growth of the colony was recorded aer 96 h of incubation.
2.6. Synthesis of Complexes. An ethanolic solution of cor-
responding ligands (each 50mL of 4mmol) was added to
an aqueous solution of 3mmol of niobioum(V) slowly with
constant stirring. e solid complexes were precipitated
immediately.e solid complexwas dried in vacuo over fused
CaCl2 (yield: 55%–62%).
3. Result and Discussion
3.1. Physical Properties. All the newly prepared complexes
are coloured, nonhygroscopic, and stable at room temper-
ature for long periods. ey do not possess sharp melting
points (>300∘C). e complexes are insoluble in water and
other common organic solvents such as ethanol, methanol,
and acetone but are soluble in DMF and DMSO. Analytical
data of the complexes are given in Table 1. e data corre-
sponds to the formula [NbO(L)(C4H4O6)]2 C4H4O6.
e molar conductance of all the complexes for 10−3M
solution in DMF at room temperature was found to be
in the range of 77–84Ohm−1 cm2mol−1 (Table 1) showing
thereby 1 : 1 electrolytic nature of the complexes. is is
consistent with the stoichiometry assumed for the complexes
on the basis of analytical data. e magnetic susceptibility
measurements carried out at room temperature were found
to be diamagnetic. Indeed all the niobium(V) complexes
reported in the literature are diamagnetic [18].
3.2. Electronic Spectra. e electronic spectra of the nio-
bium complexes in DMF show no absorption peaks in
the visible region. e free ligands show sharp band in
the 35714–38461 cm−1 region, while their corresponding
complexes exhibit sharp peaks in the 34722–37037 cm−1
region. is may be assigned to 𝜋𝜋 𝜋 𝜋𝜋∗ transition. A
weak band in the 32051–32679 cm−1 region present in the
spectra of the ligands is shied towards a higher-energy
region (32462–3112 cm−1) in the spectra of their complexes
attributable to 𝑛𝑛 𝜋 𝜋𝜋∗ transitions. e results obtained
in the electronic spectra of the complexes are presented in
Table 2.
3.3. IR Spectra. e major infrared spectral frequencies of
the ligands and the selected IR data of their niobium(V)
complexes are enumerated in Table 3. In ligands, the group
R3NH+ interacts with Cl− giving rise to a broad band
in the region 2700–2300 cm−1 [14]. In the IR spectra of
the corresponding niobium(V) complexes, these bands are
absent indicating that the tertiary nitrogen atom of the side
chain is involved in coordination to the metal ion. It was
pointed out that the heterocyclic nitrogen atom attached
to the alkyl side chain gives rise to a characteristic broad
band in the 2970–2830 cm−1 region. In the spectra of the
corresponding complexes, these bands are either absent or
shied to a higher frequency (Δ𝜈𝜈 𝜈 1𝜈 − 3𝜈 cm−1) indicating
that the heterocyclic nitrogen atom is coordinated to the
metal ion. In aromatic derivatives, 𝜈𝜈(CSC) generally appears
as a sharp band around 750 cm−1 region [19]. In the studied
niobium(V) complexes, it has been found that there is
no change in 𝜈𝜈(CSC) supporting the noncoordination of
heterocyclic sulphur atom. e bands occurring at around
1550 cm−1 and at 740 cm−1 in IPH are due to 𝜈𝜈(C=N) and
𝜈𝜈(C–S) vibrations [20, 21], respectively. e 𝜈𝜈(C=N) bands
present at 1550 and 740 cm−1 remain at the same position in
the spectra of the complexes suggesting the noninvolvement
of the pyridine ring nitrogen and heterocyclic sulphur atom
of the ligand in bonding with niobium(V) ion.
e coordination of bidentate tartrate is con�rmed
by the bands at 1710–1680 cm−1 𝜈𝜈(COO) and at
1410–1380 cm−1 𝜈𝜈(COO) [22]. Bands observed in the
495–475 cm−1 region in the spectra of the complexes
correspond to the Nb–O–Nb. Presence of 𝜈𝜈(Nb–O) modes
has been excluded because of the absence of peaks in the
560–540 cm−1 region. ese complexes also exhibit two
bands at 625–610 and at 480–460 cm−1 due to antisymmetric
vibrations of the Nb–O–Nb bridge bond, respectively.
Bands observed at 3100–3000 cm−1 region in the spectra of
phenothiazine ligands as well as their niobium(V) complexes
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T 2: Electronic spectral bands of niobium(V) complexes.
Ligand Electronic spectral bands, cm−1 Complex Electronic spectral bands, cm−1 Assignment
DMH 37594 1 38168 𝜋𝜋 𝜋 𝜋𝜋
∗
32051 32679 𝑛𝑛 𝜋 𝜋𝜋∗
IMH 37735 2 38461 𝜋𝜋 𝜋 𝜋𝜋
∗
32679 33112 𝑛𝑛 𝜋 𝜋𝜋∗
IPH 37313 3 34722 𝜋𝜋 𝜋 𝜋𝜋
∗
32467 32894 𝑛𝑛 𝜋 𝜋𝜋∗
FPH 37037 4 35714 𝜋𝜋 𝜋 𝜋𝜋
∗
32573 32671 𝑛𝑛 𝜋 𝜋𝜋∗
TMT 35714 5 36496 𝜋𝜋 𝜋 𝜋𝜋
∗
32051 32462 𝑛𝑛 𝜋 𝜋𝜋∗
T 3: Characteristic IR bands (cm−1) of the ligands and their niobium(V) complexes.
Ligands/complex 𝜈𝜈(N–CH3) 𝜈𝜈(N–CH2) Hetero 𝜈𝜈as(OCO) 𝜈𝜈s(OCO) 𝜈𝜈as(Nb–O) 𝜈𝜈s(Nb–O) 𝜈𝜈(Nb–N) 𝜈𝜈(C–S)
DMH 𝜈𝜈(NH–CH3)2830 2915 — — — — — —
1 — — 1710 1400 620 470 370 —
IMH 2655 2923 — — — — — —
2 — — 1690 1390 618 466 390 —
IPH 2560 2905 — — — — — 740
3 — — 1705 1405 610 460 380 740
FPH 2585 2895 — — — — — 760
4 — — 1695 1395 622 475 375 760
TMT 2530 2850 — — — — — 755
5 — — 1705 1385 625 485 390 755
may be assigned to 𝜈𝜈(C–H) stretching of the aromatic ring
system. e far IR spectra of studied niobium(V) complexes
exhibit medium intense bands in the region 390–350 cm−1
assigned to 𝜈𝜈(Nb–N) modes [23�. is con�rms the
participation of the nitrogen atom in coordination.
3.4. 1H-NMRStudies. e 1H-NMRspectra of the ligand IPH
and its complex are presented in Figure 2. e ligands IPH
and TMT exhibit a doublet at around 𝛿𝛿 1.3 ppm, which is
assigned to –CH–CH3, whereas the IMH, IPH, and TMT
exhibit a sharp signal (singlet) at around 𝛿𝛿 2.68 ppm due to
tertiary nitrogen attached to alkyl group, that is, –N–CH3.
e multiplet centered at 𝛿𝛿 3.58–3.52 ppm is attributed
to –N–CH2 in all the ligands. e other multiplet at 𝛿𝛿
6.78–7.82 ppm in ligands is due to aromatic protons. e
DMH showed a signal at 𝛿𝛿 9.76 ppm that is assignable to –NH
proton.
e Nb(V) complexes exhibit signals at around 𝛿𝛿 2.8 and
𝛿𝛿 3.64 ppm that indicate the shi of alkyl protons attached
to tertiary nitrogen, thereby suggesting the involvement of
tertiary nitrogen in coordination with Nb(V) ion. us 1H
NMR supports the conclusion drawn on the basis of IR
data regarding the involvement of tertiary nitrogen atoms







F 2: 1H-NMR spectra of (a) ligand IPH and (b) complex 3.
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niobium complexes, no change occurs at 𝛿𝛿 1.31 ppm and
at 𝛿𝛿 6.78–7.8 ppm assigned to alkyl and aromatic protons,
respectively. In complex 1 the signals at around 𝛿𝛿 2.85 and at 𝛿𝛿
3.33 ppm indicate a down�eld shi� of alkyl protons attached
to the secondary nitrogen and heterocyclic nitrogen, thereby
suggesting the involvement of secondary nitrogen as well as
heterocyclic nitrogen atoms in coordination with niobium
ion.
3.5. ermogravimetric Study. e decomposition tempera-
ture of the complexes obtained from their thermograms and
the data are presented in Table 4, and the thermograms of
complexes 1 and 4 are depicted in Figure 3. ermogravi-
metric study indicates that all the complexes are thermally
stable up to 220∘C and the decomposition of the complexes
takes place in two steps, namely, decomposition of organic
moiety and the loss of tartrate followed by the formation of
Nb2O5 in the temperature ranges 220–330 and 330–555∘C,
respectively. e decomposition was slow in the beginning
but rapid in later. e complexes attained constant weight
between 600 and 700∘C.eweight observed in each casewas
in full agreement with the weight loss calculated on the basis
of the stoichiometry proposed for the complexes. From the
previous spectral and thermal data, an octahedral structure
for niobium(V) complexes was predicted in Figure 4.
3.6. Evaluation of Antimicrobial Activity. e ligands DMH,
IMH, IPH, FPH, and TMT and their niobium(V) complexes
were screened separately for both antibacterial and antifungal
activities. e average percentage inhibition of both bacterial
and fungicidal growthmedia compared to the respective con-
trols was calculated by using the Vincent equation [24]. e
screening data of average percentage inhibition of bacteria
and the fungi at 30 𝜇𝜇g and at 60 𝜇𝜇g concentrations are given
in Tables 5 and 6.
e results clearly indicate that the complexes have
both antibacterial and antifungal activities against the tested
organisms. e results of the inhibitory activity of the
synthesized complexes on the organisms show that in lower
concentration the complex did not affect much on the bac-
terial and fungal growth. It shows that as the concentration
of the complex increases, the inhibition of bacterial and
fungal growth also increases. e screening of data reveals
that the niobium(V) complexes show greater antimicrobial
activity compared to the free ligands. A possible explanation
for the toxicity may be explained by chelation theory [25].
It was suggested that chelation reduces the polarity of the
metal ion considerably mainly because its positive charge is
partially shared with donor atoms and 𝜋𝜋-electron delocal-
ization over the whole chelating ring that is feasible. is
increases the lipophilic character of the metal chelates, which
favours its permeation through lipoid layers of the organism
membranes.
4. Conclusions
e molar conductance data indicate the 1 : 1 electrolytic
nature of the newly prepared niobium(V) complexes. TG
T 4: ermogravimetric data for niobium(V) complexes.
Complex Temp. range
(∘C)
Weight loss (%) Probable productFound Calc.
1 235–330 79.55 81.89 [(DM)2(C4H4O6)3]
360–540 19.32 22.35 Nb2O5
2 255–315 79.78 82.18 [(IM)2(C4H4O6)3]
340–515 19.03 21.78 Nb2O5
3 250–325 80.23 82.32 [(IP)2(C4H4O6)3]
345–520 18.82 21.59 Nb2O5
4 255–320 82.88 84.48 [(FP)2(C4H4O6)3]
330–550 16.75 18.97 Nb2O5
5 250–320 80.18 82.67 [(TM)2(C4H4O6)3]









































F 4: Suggested structure of the prepared complexes (1–5).
studies suggest that all complexes decompose in two steps,
and �nally they form their respective metal oxides. �ased on
chemical composition and physico-chemical studies, a six-
coordinated dioxobridged binuclear structure has been pro-
posed tentatively for niobium(V) complexes. e antimicro-
bial activity screened for the studied complexes against tested
bacteria and fungi shows that niobium complexes display
greater microbial toxicity compared to the free ligands.
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T 5: Antibacterial screening data of the ligands and their metal complexes.
Percentage inhibition zone (±)a
Compound S. aureus E. coli P. aregainosa B. subtilius
30𝜇𝜇g 60𝜇𝜇g 30 𝜇𝜇g 60 𝜇𝜇g 30𝜇𝜇g 60𝜇𝜇g 30𝜇𝜇g 60 𝜇𝜇g
DMH 0.0 8.5 0.0 7.4 0.0 6.0 0.0 10.2
IMH 4.4 9.7 2.6 11.5 8.2 14.7 2.8 9.2
IPH 2.7 8.7 2.2 9.2 2.4 7.4 1.2 9.3
FPH 0.0 6.2 0.0 7.4 0.0 5.9 0.0 16.0
TMT 0.0 5.4 0.0 8.3 0.0 7.5 0.0 14.2
1 8.2 19.0 6.7 22.4 8.9 22.8 6.8 21.6
2 7.6 17.4 3.5 16.8 7.5 23.3 6.7 20.3
3 9.2 33.2 10.5 36.2 7.0 27.3 8.9 26.4
4 6.3 13.1 4.5 18.2 4.7 16.4 5.3 20.6
5 5.3 11.2 4.5 16.0 4.4 15.0 5.5 16.5
Chloramphenicol 100 100 100 100 100 100 100 100
DMSO showed no inhibition, aeach value is the average of four replicates.
T 6: Antifungal screening data of the ligands and their metal
complexes.
Percentage inhibition zone (±)a
Compound A. �avus A. niger
30𝜇𝜇g 60 𝜇𝜇g 30 𝜇𝜇g 60 𝜇𝜇g
DMH 0.0 5.2 0.0 8.6
IMH 3.6 3.2 5.6 12.5
IPH 13.4 28.4 10.2 27.5
FPH 0.0 5.4 0.0 8.3
TMT 2.0 10.2 2.0 17.6
1 8.2 23.3 9.6 27.2
2 7.3 27.3 6.2 30.7
3 13.5 38.4 14.8 34.6
4 4.2 11.7 5.3 13.9
5 3.5 17.3 4.7 16.5
Griseofulvin 100 100 100 100
DMSO showed no inhibition, aeach value is the average of four replicates.
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